Search Results 361-370 of 17331 for alopecia
With normal vision, an image is sharply focused onto the surface of the retina. In nearsightedness (myopia), the point of focus is in front of the retina, ...
... alopecia in breast cancer patients. Support Care Cancer. 2023 Nov 22; 31 (12):717. View PubMed; Cathcart-Rake EJ, Tevaarwerk AJ, Haddad TC, D'Andre SD, Ruddy ...
... alopecia) and/or in whom ≥ 25% of the bone marrow was irradiated. Major surgery ≤ 14 days prior to registration or has not recovered from major side ...
- Patients who have recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > grade 1) with the exception of alopecia.
... alopecia and neuropathy - Patients who are receiving any other investigational agents - History of allergic reactions attributed to compounds of similar ...
... . VID-20464038. Home; Shaylas Story. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of cancer care.
... alopecia, peripheral neuropathy and ototoxicity, which are excluded if ≥ NCI CTCAE grade 3) due to prior cancer therapy; Chronic systemic corticosteroid use ...
* Toxicity (excluding alopecia) from prior therapy that has not been completely resolved to baseline at the time of consent. * Active or prior documented ...
... alopecia, related to anticancer therapy prior to the first dose of study drug; Major medical conditions that might affect EAP participation (e.g. ...
... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation disorder ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.